COLLASTAT
Integra LifeSciences Corporation · Decision date Dec 10, 1981
What did the FDA approve?
FDA records P810006 as an original PMA application. The recorded decision is approval, dated Dec 10, 1981.
An approval order statement is not included in the imported record. Open the FDA listing for the decision documents.
- Regulatory pathway
- Original PMA
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Dec 10, 1981
Regulatory record facts
- Identifier
- P810006
- Regulatory pathway
- Premarket approval application
- Applicant
- Integra LifeSciences Corporation
- Product code
- LMF
- Decision code
- APPR
- Decision date
- Dec 10, 1981
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Agent, absorbable hemostatic, collagen based.
- Applicant
- Integra LifeSciences Corporation
- Product code
- LMF
- FDA device class
- 3
FDA decision timeline
P810006 received
Application receipt date recorded by FDA.
P810006 · FDA decision
APPR
P810006/S115 · Related supplement
Collastat Absorbable Collagen Hemostatic Sponge and Collastat Absorbable Collagen Hemostatic Agent - Microfibrillar Fo
Timeline entries are records held by MedtechLedger for P810006. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P810006
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Integra LifeSciences Corporation | PMA supplement | Sep 18, 2026 | FDA |
Explore the linked device profile
Other records with product code LMF
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| C.R. Bard, Inc. | PMA supplement | Sep 29, 2026 | FDA | |
| Integra LifeSciences Corporation | PMA supplement | Sep 18, 2026 | FDA | |
SURGIFOAM Absorbable Gelatin SpongeP990004/S080 | Ferrosan Meidcal Devices A/S | PMA supplement | Sep 18, 2026 | FDA |
| Ferrosan Meidcal Devices A/S | PMA approval | Sep 30, 1999 | FDA | |
| Integra LifeSciences Corporation | PMA approval | Nov 8, 1985 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Integra LifeSciences Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 311 Enterprise Dr., Planisboro, NJ, 08536
Sources and methodology
- Original FDA record: P810006
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
